Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. | Mol Ther | 2022 | 35176485 | PubTator, text mining | PubMed |
| Genetic and biological characteristics of species A rotaviruses detected in common shrews suggest a distinct evolutionary trajectory. | Virus Evol | 2022 | 35169491 | PubTator, text mining | PubMed |
| The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern. | Nat Commun | 2022 | 35169114 | PubTator, text mining | PubMed |
| Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication. | Molecules | 2022 | 35164317 | PubTator, text mining | PubMed |
| Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp). | Molecules | 2022 | 35164069 | PubTator, text mining | PubMed |
| DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design. | Molecules | 2022 | 35163948 | PubTator, text mining | PubMed |
| SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. | Int J Mol Sci | 2022 | 35163638 | PubTator, text mining | PubMed |
| Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19. | Cureus | 2022 | 35154957 | PubTator, text mining | PubMed |
| Rotavirus-Mediated Prostaglandin E2 Production in MA104 Cells Promotes Virus Attachment and Internalisation, Resulting in an Increased Viral Load. | Front Physiol | 2022 | 35153833 | PubTator, text mining | PubMed |
| Drug repurposing against SARS-CoV-2 using computational approaches. | Drug Discov Today | 2022 | 35151891 | PubTator, text mining | PubMed |
| Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) cultivars using UPLC-MS/MS coupled to chemometric analysis, in vitro study and molecular docking. | J Ethnopharmacol | 2022 | 35151836 | PubTator, text mining | PubMed |
| Type I interferons and SARS-CoV-2: from cells to organisms. | Curr Opin Immunol | 2022 | 35149239 | PubTator, text mining | PubMed |
| A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. | PLoS Pathog | 2022 | 35143592 | PubTator, text mining | PubMed |
| Screening of potential inhibitors of COVID-19 with repurposing approach via molecular docking. | Netw Model Anal Health Inform Bioinform | 2022 | 35136710 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients. | J Adv Res | 2022 | 35116173 | PubTator, text mining | PubMed |
| SARS-CoV-2 Genome Sequence Obtained from Ethiopia. | Microbiol Resour Announc | 2022 | 35112893 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
| SARS-CoV-2 Inhibitors from Nigella Sativa. | Appl Biochem Biotechnol | 2022 | 35102539 | PubTator, text mining | PubMed |
| 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis. | Antiviral Res | 2022 | 35101534 | PubTator, text mining | PubMed |
| Effects of Human Nucleolus Upon Guest Viral-Life, Focusing in COVID-19 Infection: A Mini- Review. | Iran J Pathol | 2022 | 35096082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=60